Oropharyngeal dysphagia in dermatomyositis: Associations with clinical and laboratory features including autoantibodies

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Mugii, Naoki ^a   Hasegawa, Minoru ^b   Matsushita, Takashi ^c   Hamaguchi, Yasuhito ^c   Oohata, Sacihe ^a   Okita, Hirokazu ^a   Yahata, Tetsutarou ^a   Someya, Fujiko ^c   Inoue, Katsumi ^c   Murono, Shigeyuki ^c   Fujimoto, Manabu ^d   Takehara, Kazuhiko ^c  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOACYL TRNA SYNTHETASE ANTIBODY; AUTOANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5 ANTIBODY; METHYLPREDNISOLONE; MI 2 ANTIBODY; PREDNISOLONE; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SIGNAL RECOGNITION PARTICLE ANTIBODY; TRANSCRIPTION INTERMEDIARY FACTOR 1 GAMMA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DELTOID MUSCLE; DERMATOMYOSITIS; DYSPHAGIA; FEMALE; FLUOROSCOPY; HUMAN; IMMUNOPRECIPITATION; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MANUAL MUSCLE TESTING; MIDDLE AGED; MUSCLE EXAMINATION; MUSCLE WEAKNESS; NEOPLASM; OROPHARYNX; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; STERNOCLEIDOMASTOID MUSCLE; VIDEOFLUOROSCOPY SWALLOW STUDY; COMPLICATION; IMMUNOLOGY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; SWALLOWING; VIDEORECORDING;

AUTOANTIBODIES; DEGLUTITION; DEGLUTITION DISORDERS; DERMATOMYOSITIS; FEMALE; FLUOROSCOPY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; VIDEO RECORDING;

EID: 84969785372     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154746     Document Type: Article

References (25)

1. Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc. 2007; 82:441-7. PMID: 17418072
2. Williams RB, Grehan MJ, Hersch M, Andre J, Cook IJ. Biomechanics, diagnosis, and treatment outcome in inflammatory myopathy presenting as oropharyngeal dysphagia. Gut. 2003; 52:471-8. PMID: 12631653
3. Ebert EC. Review article: the gastrointestinal complications of myositis. Aliment Pharmacol Ther. 2010;31:359-65. doi: 10.1111/j.1365-2036.2009.04190.x PMID: 19886949
4. Ponyi A, Constantin T, Garami M, Andras C, Tallai B, Vancsa A, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005; 1051:64-71. PMID: 16126945
5. Azuma K, Yamada H, Ohkubo M, Yamasaki Y, Yamasaki M, Mizushima M, et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol. 2011; 21:178-83. doi: 10.1007/s10165-010-0362-y PMID: 20922453
6. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol. 2007; 19:523-9. PMID: 17917530
7. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, et al. A novel autoAb to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006; 54:3682-9. PMID: 17075819
8. Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007; 46:25-8.
9. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis. 2007; 66:1345-9. PMID: 17392346
10. Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, et al. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 2012; 64:513-22. doi: 10.1002/art.33403 PMID: 21987216
11. Trallero-Araguas E, Rodrigo-Pendas JA, Selva-O'Callaghan A, Martinez-Gomez X, Bosch X, Labrador-Horrillo M, et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum. 2012; 64:523-32. doi: 10.1002/art.33379 PMID: 21953614
12. Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002; 28:859-90. PMID: 12506776
13. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005; 52:1571-6. PMID: 15880816
14. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009; 60:2193-200. doi: 10.1002/art.24621 PMID: 19565506
15. Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, et al. Anti-Mi-2 antibodies. Autoimmunity. 2005 Feb; 38:79-83. PMID: 15966133
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Eng J Med. 1975; 292:344-8.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Eng J Med. 1975; 292:403-7.
18. Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol. 1999; 11:475-82. PMID: 10551671
19. Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest. 1995; 108:311-5. PMID: 7634858
20. Sultan SM, Allen E, Oddis CV, Kiely P, Cooper RG, Lundberg IE, et al. Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum. 2008; 58:3593-9. doi: 10.1002/art.23963 PMID: 18975333
21. Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, et al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford). 2008; 47:324-8.
22. Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, et al. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis. 2009; 68:1621-5. doi: 10.1136/ard.2008.097162 PMID: 18930994
23. Fujimoto M, Matsushita T, Hamaguchi Y, Kaji K, Asano Y, Ogawa F, et al. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis. 2013; 72:151-3. doi: 10.1136/annrheumdis-2012-201736 PMID: 22843487
24. McCann LJ, Garay SM, Ryan MM, Harris R, Riley P, Pilkington CA. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores. Rheumatology (Oxford). 2007; 46:1363-6.
25. Langdon CP, Mulcahy K, Shepherd KL, Low VH, Mastaglia FL. Pharyngeal Dysphagia in Inflammatory Muscle Diseases Resulting from Impaired Suprahyoid Musculature. Dysphagia. 2012; 27:408-17. doi: 10.1007/s00455-011-9384-7 PMID: 22207246